MTC/ NTM Assay
Product Overview
The assay is an automated, in vitro nucleic acid amplification test used for qualitative diagnosis of Mycobacterium Tuberculosis Complex (MTC) and d Non-Tuberculosis. Mycobaceria (NTM) in sputum from suspected case with signs and/or symptoms of MTC/NTM infection.
- Result obtained within 54 mins
- Direct diagnosis design to provide an accurate LOD: MTC100 copies/mL, NTM 1000cps/mL
- The detected target: IS6110+1081+16srRNA
- Differentiated MTC/NTM results facilitate physicians to provide appropriate treatment to patients
- Point-of-care Nucleic Acid Test Methodology to be applied in various medical scenarios
Ongoing Challenges
- NTM can cause infections in a wide variety of body sites, including lungs, lymph gland, bone, joint, skin, soft tissue, and other organs, leading to disseminated diseases in the body.
- Both NTM and TB can present with similar clinical symptoms and Chest X-rays, CT scans and Acid-Fast Bacilli (AFB) Smear may show similar findings in both conditions.
- Enable precise and timely treatment, achieving Point-of-Care testing, and reducing turn-around time. Break the limitations of testing scenarios, enhance the surveillance level.
Clinical Value
- Significantly improves preliminary screening of suspected MTC/NTM cases
- Auxiliary solution of bacteria-negative tuberculosis and extra-pulmonary tuberculosis
- A cost-effective and time-efficient implementation for differentiating MTC/NTM
Product Resources
EasyNAT® MTC/ NTM Assay
Brochure
